Diurnal changes in the perception of emotions in music: Does the time of day matter?

According to the Hindustani music tradition, the ability of a song to induce certain emotions depends on the time of day: playing a song at the right time is said to maximise its emotional effect. The present exploratory study investigated this claim by combining findings in chronobiology, mood research and music perception. It has already been established that some aspects of our mood fluctuations follow a cyclical pattern. Besides, it is a known fact that our current mood influences our perception and assessment of emotions. However, these elements have never been linked together in a study examining the effect of mood cyclicity on perceived emotions in music. To test the hypothesis of a link between the two, Western film music excerpts were played to 36 participants at two different times (9 am and 4 pm). Their task was to rate the perceived emotional content of each clip. The results showed that sad and tender clips were rated higher on sadness and tenderness in the morning compared to the afternoon. Furthermore, the more tired the participants were in the afternoon, the higher was their perception of fear in angry and fearful music. Although the reported effect sizes were small, these findings could have important implications for ethnomusicologists, emotion researchers and music therapists.peerReviewe

Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation:rationale and design of the POPular PAUSE TAVI trial

About one-third of patients undergoing transcatheter aortic valve implantation (TAVI) use oral anticoagulants (OAC), mainly due to atrial fibrillation. General guidelines advise interrupting OAC in patients with a high risk of bleeding undergoing interventions. However, preliminary observational data suggest that the continuation of OAC during TAVI is safe and may reduce the risk of periprocedural thromboembolic events. The Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI) is a multicentre, randomised clinical trial with open-label treatment and blinded endpoint assessment. Patients are randomised 1:1 to periprocedural continuation versus interruption of OAC and are stratified for vitamin K antagonist or direct oral anticoagulant use. The primary endpoint is a composite of cardiovascular mortality, all stroke, myocardial infarction, major vascular complications and type 2-4 bleeding within 30 days after TAVI, according to the Valve Academic Research Consortium-3 criteria. Secondary endpoints include separate individual and composite outcomes, quality of life and cost-effectiveness. Since continuation of OAC is associated with the ancillary benefit that it simplifies periprocedural management, the primary outcome is first analysed for non-inferiority; if non-inferiority is proven, superiority will be tested. Recruitment started in November 2020, and the trial will continue until a total of 858 patients have been included and followed for 90 days. In summary, POPular PAUSE TAVI is the first randomised clinical trial to assess the safety and efficacy of periprocedural continuation versus interruption of OAC in patients undergoing TAVI